FDA says no, thank you to Xpovio’s cancer expansion bid, prompting Karyopharm to run new study

FDA says no, thank you to Xpovio’s cancer expansion bid, prompting Karyopharm to run new study
aliu
Wed, 03/02/2022 – 10:09